| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47781-103-21 | 47781-103 | HUMAN PRESCRIPTION DRUG | IBANDRONATE SODIUM | IBANDRONATE SODIUM | TABLET | ORAL | 20191218 | N/A | ANDA | ANDA078998 | Alvogen Inc. | IBANDRONATE SODIUM | 150 mg/1 | 1 BLISTER PACK in 1 CARTON (47781-103-21) / 3 TABLET in 1 BLISTER PACK |
| 47781-103-33 | 47781-103 | HUMAN PRESCRIPTION DRUG | IBANDRONATE SODIUM | IBANDRONATE SODIUM | TABLET | ORAL | 20140501 | N/A | ANDA | ANDA078998 | Alvogen Inc. | IBANDRONATE SODIUM | 150 mg/1 | 3 BLISTER PACK in 1 BOX (47781-103-33) / 1 TABLET in 1 BLISTER PACK (47781-103-07) |
| 69452-378-74 | 69452-378 | HUMAN PRESCRIPTION DRUG | IBANDRONATE SODIUM | IBANDRONATE SODIUM | TABLET | ORAL | 20230526 | N/A | ANDA | ANDA078998 | Bionpharma Inc. | IBANDRONATE SODIUM | 150 mg/1 | 1 BLISTER PACK in 1 CARTON (69452-378-74) / 3 TABLET in 1 BLISTER PACK |